Abstract |
The effects of polymorphisms of ABCB1 and ABCG2 on the dose-adjusted plasma trough concentrations and cerebrospinal fluid (CSF)-to-plasma ratios of ponatinib were evaluated. Blood (C4 ) and CSF (CSF4 ) concentrations at 4 h after administration were determined. The median (95% confidence interval) CSF4 -to-C4 ratio of ponatinib in subjects homozygous for ABCB1 variants 1236T/T, 2677T/T + T/A or 3435T/T were significantly higher than that in a group of subjects with other genotypes (P = .026, .012 and .015, respectively). The median (95% confidence interval) CSF4 -to-C4 ratio of ponatinib in 4 patients with the combination of ABCB1 variants 1236T/T-2677T/T + T/A-3435T/T was 2.62% (1.42-3.42%); this ratio was significantly higher than that in subjects with other genotypes (1.08% [0.89-1.47%]; P = .006). The brain distribution of ponatinib was affected by ABCB1 polymorphisms and therefore seems to be modulated by P-glycoprotein at the blood-brain and blood-CSF barriers.
|
Authors | Yayoi Fukushi, Yumiko Akamine, Maiko Abumiya, Nagi Tozawa, Takaya Yamashita, Miho Nara, Yoshihiro Kameoka, Naoto Takahashi, Masatomo Miura |
Journal | British journal of clinical pharmacology
(Br J Clin Pharmacol)
Vol. 89
Issue 5
Pg. 1695-1700
(05 2023)
ISSN: 1365-2125 [Electronic] England |
PMID | 36541130
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 British Pharmacological Society. |
Chemical References |
- ponatinib
- ATP Binding Cassette Transporter, Subfamily B
- ABCB1 protein, human
|
Topics |
- Humans
- Philadelphia Chromosome
- East Asian People
- ATP Binding Cassette Transporter, Subfamily B
(genetics)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, genetics)
- Polymorphism, Single Nucleotide
|